Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep;123(6):871-873.
doi: 10.1038/s41416-020-0926-3. Epub 2020 Jun 26.

How promising is phototherapy for cancer?

Affiliations

How promising is phototherapy for cancer?

Huayun Shi et al. Br J Cancer. 2020 Sep.

Abstract

Oncological phototherapy, including current photodynamic therapy (PDT), developmental photoactivated chemotherapy (PACT) and photothermal therapy (PTT), shows promising photo-efficacy for superficial and internal tumours. The dual application of light and photochemotherapeutic agents allows accurate cancer targeting, low invasiveness and novel mechanisms of action. Current advances in new light sources and photoactive agents are encouraging for future development.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
a FDA-approved anticancer photosensitisers; b metal-based photoactive anticancer complexes under development.

References

    1. van Straten D, Mashayekhi V, de Bruijn H, Oliveira S, Robinson D. Oncologic photodynamic therapy: basic principles, current clinical status and future directions. Cancers. 2017;9:19. doi: 10.3390/cancers9020019. - DOI - PMC - PubMed
    1. Imberti C, Zhang P, Huang H, Sadler PJ. New designs for phototherapeutic transition metal complexes. Angew. Chem. Int. Ed. 2020;59:61–73. doi: 10.1002/anie.201905171. - DOI - PMC - PubMed
    1. Monro S, Colón KL, Yin H, Roque J, Konda P, Gujar S, Thummel RP, Lilge L, Cameron CG, McFarland SA. Transition metal complexes and photodynamic therapy from a tumor-centered approach: challenges, opportunities, and highlights from the development of TLD1433. Chem. Rev. 2019;119:797–828. doi: 10.1021/acs.chemrev.8b00211. - DOI - PMC - PubMed
    1. Brancaleon L, Moseley H. Laser and non-laser light sources for photodynamic therapy. Lasers Med. Sci. 2002;17:173–186. doi: 10.1007/s101030200027. - DOI - PubMed
    1. Morton CA, Braathen LR. Daylight photodynamic therapy for actinic keratoses. Am. J. Clin. Dermatol. 2018;19:647–656. doi: 10.1007/s40257-018-0360-y. - DOI - PubMed

Publication types

Substances